0001209191-21-020633.txt : 20210315 0001209191-21-020633.hdr.sgml : 20210315 20210315213542 ACCESSION NUMBER: 0001209191-21-020633 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210311 FILED AS OF DATE: 20210315 DATE AS OF CHANGE: 20210315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEST MICHAEL D CENTRAL INDEX KEY: 0001202529 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 21743412 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE, SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AgeX Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 821436829 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 510-671-8370 MAIL ADDRESS: STREET 1: 965 ATLANTIC AVENUE STREET 2: SUITE 101 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-11 0 0001708599 AgeX Therapeutics, Inc. AGE 0001202529 WEST MICHAEL D 1101 MARINA VILLAGE PARKWAY, SUITE 201 ALAMEDA CA 94501 1 1 0 0 Chief Executive Officer Common Stock, $0.0001 par value 2021-03-11 4 M 0 3125 0.00 A 33723 D Common Stock, $0.0001 par value 2021-03-11 4 F 0 1284 2.03 D 32439 D Restricted Stock Units 0.00 2021-03-11 4 M 0 3125 0.00 D Common Stock 3125 25000 D Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4. Restricted Stock Units vested on March 11, 2021. /s/Michael D. West 2021-03-15